-
Patient PerspectivesFuture of HealthcareMedical InnovationsNeurodegenerative DiseaseLongevity with vitality: Japanese elders provide examples for healthy aging
Ogimi in Okinawa, Japan has the highest percentage of centenarians in the world, making it a curiosity for those eager to learn more about the secrets of aging.
Patient Perspectives -
DiscoveryNovartis Institutes for BioMedical ResearchTargeted TherapyCancer cocktails come of age
Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchCancer cocktails: LEE011 – a popular combination partner
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchCancer cocktails: LJM716 – closing a common release valve
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchCancer cocktails: ABL001 – hitting one target twice
Discovery -
From Our LabsAccess to HealthcareDigitalEmerging TechnologyMobile DevicesmHealth: A revolution in healthcare
Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.
From Our Labs -
Patient PerspectivesDisease AwarenessLiving With DiseasePatient EducationExperts call for new approach to patient and physician management of type 2 diabetes
A global survey revealed major disconnects in communication, disease awareness and expectations between patients and physicians.
Patient Perspectives -
DiscoveryCancerFuture of HealthcareInnovationCombination therapies: Seeking to block cancer’s pathways to growth
Talk to any cancer researcher or doctor today and what you hear is wonder and hope.
Discovery -
From Our LabsNovartis Institutes for BioMedical ResearchWhy Novartis scouts for disruptive technology
Cambridge neighbors, NIBR and Harvard, further disrupt technology. Read how their alliance is accelerating drug discovery.
From Our Labs -
Patient PerspectivesDisease AwarenessHeart FailureLiving With DiseasePatient EducationMost Europeans have limited awareness about heart failure
The majority of Europeans can’t identify the warning signs of heart failure, a life threatening disease, which affects one in five people in the region.
Patient Perspectives -
From Our LabsDigitalDrug DiscoveryEmerging TechnologyFuture of HealthcareInnovationRobots speed the pace of modern drug discovery
Novartis researchers use automation to rapidly identify starting points for new drugs.
From Our Labs -
Patient PerspectivesChronic IllnessHeart FailureLiving With DiseasePatient EducationLiving with heart failure
Heart failure affects 26 million people worldwide. More people die from heart failure than from some advanced cancers, including breast and bowel cancer.
Patient Perspectives
Pagination
- ‹ Previous page
- 1
- …
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- › Next page